Literature DB >> 2166558

Characterization of particulate cyclic nucleotide phosphodiesterases from bovine brain: purification of a distinct cGMP-stimulated isoenzyme.

S Murashima1, T Tanaka, S Hockman, V Manganiello.   

Abstract

In the absence of detergent, approximately 80-85% of the total cGMP-stimulated phosphodiesterase (PDE) activity in bovine brain was associated with washed particulate fractions; approximately 85-90% of the calmodulin-sensitive PDE was soluble. Particulate cGMP-stimulated PDE was higher in cerebral cortical gray matter than in other regions. Homogenization of the brain particulate fraction in 1% Lubrol increased cGMP-stimulated activity approximately 100% and calmodulin-stimulated approximately 400-500%. Although 1% Lubrol readily solubilized these PDE activities, approximately 75% of the cAMP PDE activity (0.5 microM [3H]cAMP) that was not affected by cGMP was not solubilized. This cAMP PDE activity was very sensitive to inhibition by Rolipram but not cilostamide. Thus, three different PDE types, i.e., cGMP stimulated, calmodulin sensitive, and Rolipram inhibited, are associated in different ways with crude bovine brain particulate fractions. After solubilization and purification by chromatography on cGMP-agarose, heparin-agarose, and Superose 6, the brain particulate cGMP-stimulated PDE cross-reacted with antibody raised against a cGMP-stimulated PDE purified from calf liver supernatant. The brain enzyme exhibited a slightly greater subunit Mr than did soluble forms from calf liver or bovine brain, as evidenced by protein staining or immunoblotting after polyacrylamide gel electrophoresis under denaturing conditions. Incubation of brain particulate and liver soluble cGMP-stimulated PDEs with V8 protease produced several peptides of similar size, as well as at least two distinct fragments of approximately 27 kDa from the brain and approximately 23 kDa from the liver enzyme.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2166558     DOI: 10.1021/bi00474a010

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  5 in total

1.  Photoaffinity labelling of cyclic GMP-binding proteins in human platelets.

Authors:  K M Tang; J L Sherwood; R J Haslam
Journal:  Biochem J       Date:  1993-09-01       Impact factor: 3.857

2.  Cyclic GMP-phosphodiesterase inhibition does not alter cerebral oxygen consumption.

Authors:  H M Wei; A J Shah; J Tse; O Z Chi; H R Weiss
Journal:  Neurochem Res       Date:  1996-01       Impact factor: 3.996

3.  Dual acylation of PDE2A splice variant 3: targeting to synaptic membranes.

Authors:  Corina Russwurm; Georg Zoidl; Doris Koesling; Michael Russwurm
Journal:  J Biol Chem       Date:  2009-07-24       Impact factor: 5.157

4.  Role of phosphodiesterase 2 in growth and invasion of human malignant melanoma cells.

Authors:  Kenichi Hiramoto; Taku Murata; Kasumi Shimizu; Hiroshi Morita; Madoka Inui; Vincent C Manganiello; Toshiro Tagawa; Naoya Arai
Journal:  Cell Signal       Date:  2014-04-03       Impact factor: 4.315

5.  Functional Proteomic Profiling of Phosphodiesterases Using SeraFILE Separations Platform.

Authors:  Amita R Oka; Matthew P Kuruc; Ketan M Gujarathi; Swapan Roy
Journal:  Int J Proteomics       Date:  2012-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.